Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report

التفاصيل البيبلوغرافية
العنوان: Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report
المؤلفون: Oda, Nao, Tamai, Koji, Suzuki, Yujiro, Yoshimatsu, Harukazu, Matsuoka, Hirofumi, Matsumoto, Yusuke, Okada, Nobuhiko
بيانات النشر: BioMed Central Ltd.
سنة النشر: 2015
المجموعة: BioMed Central
مصطلحات موضوعية: Autoimmune pulmonary alveolar proteinosis, Ambroxol, Severe hypoxemia
الوصف: Introduction Pulmonary alveolar proteinosis is characterized by accumulation of surfactant and phospholipids in the pulmonary alveoli. Whole lung lavage is considered the first-line therapy, which requires special techniques. To the best of our knowledge, there have only been limited reports that have demonstrated the effectiveness of ambroxol on a mild case of pulmonary alveolar proteinosis. Case presentation A 72-year-old Japanese woman presented to our hospital with a one-year history of productive cough and progressive dyspnea. Her chest computed tomography scan showed a bilateral crazy-paving pattern in both of her lungs. She was diagnosed with autoimmune pulmonary alveolar proteinosis based on bronchoalveolar lavage findings and the presence of serum anti-granulocyte macrophage colony-stimulating factor antibodies. She was severely hypoxemic, so we recommended whole lung lavage or inhaled granulocyte macrophage colony-stimulating factor treatment, which she refused. We initiated treatment with ambroxol and her symptoms markedly improved. Conclusions Although whole lung lavage is the first-line therapy for pulmonary alveolar proteinosis, oral ambroxol could be an alternative treatment option, even in patients with severe respiratory compromise.
نوع الوثيقة: report
اللغة: English
العلاقة: http://www.jmedicalcasereports.com/content/9/1/100Test
الإتاحة: http://www.jmedicalcasereports.com/content/9/1/100Test
حقوق: Copyright 2015 Oda et al.; licensee BioMed Central.
رقم الانضمام: edsbas.35EC2BA3
قاعدة البيانات: BASE